UroGen Pharma Ltd. — All Filings
541 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
20-F
3
3/A
4
4/A
424B4
424B5
6-K
8-A12B
8-K
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K | FORM 10-K | 0001437749-26-006234 | Mar 2, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0001437749-26-006233 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001193125-26-084282 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | FORM 4 | 0001437749-26-006124 | Feb 27, 2026 | Feb 26, 2026 |
| 4 | FORM 4 | 0001437749-26-004638 | Feb 19, 2026 | Jan 31, 2026 |
| 4 | FORM 4 | 0001437749-26-003778 | Feb 11, 2026 | Jan 31, 2026 |
| 4 | FORM 4 | 0001437749-26-003040 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | FORM 4 | 0001437749-26-002843 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | FORM 4 | 0001437749-26-002841 | Feb 3, 2026 | Jan 31, 2026 |
| 144 | — | 0001976408-26-000031 | Feb 3, 2026 | — |
| 4 | FORM 4 | 0001437749-25-036576 | Dec 1, 2025 | Nov 26, 2025 |
| 4 | FORM 4 | 0001437749-25-036565 | Dec 1, 2025 | Nov 26, 2025 |
| 4 | FORM 4 | 0001437749-25-036559 | Dec 1, 2025 | Nov 26, 2025 |
| 4 | FORM 4 | 0001437749-25-036557 | Dec 1, 2025 | Nov 26, 2025 |
| 4 | FORM 4 | 0001437749-25-036555 | Dec 1, 2025 | Nov 26, 2025 |
| 4 | FORM 4 | 0001437749-25-035821 | Nov 20, 2025 | Nov 19, 2025 |
| 144 | — | 0001000275-25-000163 | Nov 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-112620 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001771015-25-000010 | Nov 14, 2025 | — |
| S-8 | S-8 | 0001193125-25-269706 | Nov 6, 2025 | — |
| S-3ASR | S-3ASR | 0001193125-25-269643 | Nov 6, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-033468 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-033466 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0001437749-25-030772 | Oct 9, 2025 | Oct 8, 2025 |
| 4 | FORM 4 | 0001437749-25-028707 | Sep 9, 2025 | Sep 7, 2025 |
| 4 | FORM 4 | 0001437749-25-028705 | Sep 9, 2025 | Sep 7, 2025 |
| 144 | — | 0001976408-25-000296 | Sep 9, 2025 | — |
| 144 | — | 0001976408-25-000295 | Sep 9, 2025 | — |
| 4 | FORM 4 | 0001437749-25-027883 | Aug 27, 2025 | Aug 26, 2025 |
| 4 | FORM 4 | 0001437749-25-027882 | Aug 27, 2025 | Aug 26, 2025 |
| 4 | FORM 4 | 0001437749-25-027880 | Aug 27, 2025 | Aug 26, 2025 |
| 4 | FORM 4 | 0001437749-25-027879 | Aug 27, 2025 | Aug 26, 2025 |
| 4 | FORM 4 | 0001437749-25-027878 | Aug 27, 2025 | Aug 26, 2025 |
| 4 | FORM 4 | 0001437749-25-027877 | Aug 27, 2025 | Aug 26, 2025 |
| 8-K | FORM 8-K | 0001437749-25-027874 | Aug 27, 2025 | Aug 26, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-022035 | Aug 14, 2025 | — |
| 4 | FORM 4 | 0001437749-25-026377 | Aug 13, 2025 | Aug 11, 2025 |
| SCHEDULE 13G | — | 0001104659-25-076875 | Aug 12, 2025 | — |
| 10-Q | FORM 10-Q | 0001437749-25-025243 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | FORM 8-K | 0001437749-25-025242 | Aug 7, 2025 | — |
| SCHEDULE 13G/A | — | 0001213900-25-072156 | Aug 5, 2025 | — |
| 4 | FORM 4 | 0001437749-25-023969 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | FORM 4 | 0001437749-25-023963 | Jul 30, 2025 | Jul 28, 2025 |
| 4 | FORM 4 | 0001437749-25-023961 | Jul 30, 2025 | Jul 28, 2025 |
| SCHEDULE 13G/A | — | 0001085146-25-004272 | Jul 29, 2025 | — |
| 144 | — | 0001976408-25-000249 | Jul 29, 2025 | — |
| 144 | — | 0001976408-25-000248 | Jul 29, 2025 | — |
| ARS | ANNUAL REPORT | 0001437749-25-022781 | Jul 16, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | — | 0002052113-25-002462 | Jul 16, 2025 | — |
| DEF 14A | FORM DEF 14A | 0001437749-25-022732 | Jul 15, 2025 | Aug 11, 2025 |